258 filings
Page 6 of 13
8-K
yti 2ceofi5
30 Oct 18
Acceleron Reports Third Quarter 2018 Operating and Financial Results
4:10pm
CT ORDER
8p1 268a0rr5rls
4 Sep 18
Confidential treatment order
12:00am
8-K
vp3y 3qjdvf0mq4
2 Aug 18
Acceleron Reports Second Quarter 2018 Operating and Financial Results
4:15pm
8-K
tdt6cmkj069ssikgya
26 Jul 18
Acceleron Announces Preliminary Results from Part 1 of the ACE-083 Phase 2 Trial
4:30pm
8-K
y9buem04
9 Jul 18
Results showed a significant reduction in transfusion burden compared to placebo
5:01pm
8-K
ofdzq82trq 9o
28 Jun 18
Results showed significant improvement in red blood cell transfusion independence compared to placebo
5:09pm
8-K
qecd63re2isl5bm
20 Jun 18
Other Events
4:44pm
8-K
yg1zgsht
7 Jun 18
Submission of Matters to a Vote of Security Holders
5:24pm
8-K
8dve528
5 Jun 18
Acceleron Announces Updated Results from Ongoing Phase 2 Trials of Luspatercept in Myelodysplastic Syndromes at the ASCO 2018 Annual Meeting
4:43pm
8-K
glu82c
11 May 18
Departure of Directors or Certain Officers
4:58pm
8-K
k7q0 t26yme
8 May 18
Acceleron Reports First Quarter 2018 Operating and Financial Results
4:10pm
8-K
fc19is6lxgect4 q1
16 Apr 18
Departure of Directors or Certain Officers
12:00am
DEFA14A
fhew9z6i4fm
13 Apr 18
Additional proxy soliciting materials
12:00am
S-8
aeszzm 7u
27 Feb 18
Registration of securities for employees
12:00am
8-K
z9j qxdzlm
27 Feb 18
Acceleron Reports Fourth Quarter and Full Year 2017 Operating and Financial Results
12:00am